HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Brega Selected Research

5- ((5- fluoro- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)methyl)- N- (2- hydroxy- 3- morpholin- 4- ylpropyl)- 2,4- dimethyl- 1H- pyrrole- 3- carboxamide

1/2011Phase I trial of SU14813 in patients with advanced solid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Brega Research Topics

Disease

1Melanoma (Melanoma, Malignant)
06/2011
1Neoplasms (Cancer)
01/2011

Drug/Important Bio-Agent (IBA)

1Sunitinib (Sutent)FDA Link
06/2011
15- ((5- fluoro- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)methyl)- N- (2- hydroxy- 3- morpholin- 4- ylpropyl)- 2,4- dimethyl- 1H- pyrrole- 3- carboxamideIBA
01/2011
1Tyrosine Kinase InhibitorsIBA
01/2011